The CNS Tumour Methylation Classifier can categorise brain tumours into subtypes, offering more accurate and personalised ...

DNA synthesis is vital to several processes in biopharmaceutical innovation, including the development of gene therapies, CRISPR gene editing, antisense oligonucleotides and RNA therapies.

MedGenome has introduced the first CNS Tumor Methylation Classifier Test in India. This innovative diagnostic tool can ...

Recent advances in epigenetics research provide more clues as to why identical twins are different and offer ways to treat ...

A CNS Tumor Methylation Classifier is an advanced diagnostic tool that classifies central nervous system (CNS) tumors by analyzing DNA methylation patterns.

This means that a test measuring modifications on microbial RNA can detect possible cancerous activity much earlier than tests that rely on DNA released by human tumor cells. Commercial tests that ...

Scientists have achieved the first DNA-free CRISPR gene editing in raspberries, reaching 19% efficiency and opening the door to faster breeding of firmer, more resilient berries — though regenerating ...

EPFL researchers have developed Systema, a new tool to evaluate how well AI models work when predicting the effects of genetic perturbations.

Modern crop breeding is entering a new era of genome design, led by genome editing technologies as mainstream tools for targeted genome modification. In a review published in Nature Reviews ...

MedGenome launches India’s first whole genome test for precise brain tumour classification: Our Bureau, Bengaluru Thursday, August 28, 2025, 14:30 Hrs [IST] MedGenome has launch ...